Holen Sie sich die Stockscreener-App
30.81
4.49%
-1.48
Handel nachbörslich:
30.81
Schlusskurs vom Vortag:
$32.29
Offen:
$33.03
24-Stunden-Volumen:
605.65K
Relative Volume:
1.84
Marktkapitalisierung:
$221.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-112.46M
KGV:
-18.79
EPS:
-1.64
Netto-Cashflow:
$-99.89M
1W Leistung:
-8.76%
1M Leistung:
-11.38%
6M Leistung:
+123.15%
1J Leistung:
+132.05%
1-Tages-Spanne:
$29.20
$33.03
1-Wochen-Bereich:
$29.20
$34.63
52-Wochen-Spanne:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vergleichen Sie VOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
30.81 | 221.31M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Vor Biopharma stock rises after positive Phase 3 results for Sjögren’s treatment - Investing.com Australia
Vor Bio rises after partner RemeGen succeeds in Sjögren’s disease study - Seeking Alpha
Vor Bio (VOR) and RemeGen Report Strong Phase 3 Results for Teli - GuruFocus
Can machine learning forecast Vor Biopharma Inc. recoveryJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Reprogrammed Interchange Llc Sells 48,884 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Sells $2,549,123.94 in Stock - MarketBeat
Vor Biopharma Inc.'s (NASDAQ:VOR) Intrinsic Value Is Potentially 55% Above Its Share Price - simplywall.st
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock - Investing.com
Is Vor Biopharma Inc. stock poised for growth2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Vor Biopharma Inc. stock2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
What indicators show strength in Vor Biopharma Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Vor Biopharma Inc. stock2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Vor Biopharma Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Vor Biopharma's (VOR) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 70,763 Shares - MarketBeat
Vor biopharma $3.5m stock sale by ten percent owner - Investing.com Australia
Relative strength of Vor Biopharma Inc. in sector analysisJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 02:38:01 - newser.com
Vor biopharma $3.5m stock sale by ten percent owner By Investing.com - Investing.com Australia
Can momentum traders help lift Vor Biopharma Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com
Applying sector rotation models to Vor Biopharma Inc.2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Will Vor Biopharma Inc. bounce back from current support2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Reprogrammed Interchange Llc Sells 7,901 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 32,451 Shares - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 1,400 Shares - MarketBeat
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
76,360 Stock Options — Vor Bio Grants Options at $30.40 and RSUs to New Hires - Stock Titan
Tick level data insight on Vor Biopharma Inc. volatilityJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-03 00:08:46 - newser.com
Vor Biopharma Inc. $VOR Shares Acquired by Goldman Sachs Group Inc. - MarketBeat
Vor Bio Surges: Analysts See Bright Future - timothysykes.com
Published on: 2025-09-30 05:10:46 - newser.com
Vor Biopharma (VOR) Price Target Increased by 2,942.55% to 36.46 - Nasdaq
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vor Biopharma Inc-Aktie (VOR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Oct 09 '25 |
Sale |
32.07 |
48,884 |
1,567,611 |
1,374,775 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 06 '25 |
Sale |
37.01 |
70,763 |
2,618,788 |
1,526,545 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 07 '25 |
Sale |
33.84 |
27,624 |
934,711 |
1,498,921 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 02 '25 |
Sale |
39.83 |
32,451 |
1,292,457 |
1,605,209 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 03 '25 |
Sale |
37.83 |
7,901 |
298,911 |
1,597,308 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 01 '25 |
Sale |
39.19 |
1,400 |
54,870 |
1,637,660 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 16 '25 |
Sale |
1.54 |
447,278 |
688,853 |
32,781,209 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 15 '25 |
Sale |
1.64 |
400,000 |
656,320 |
33,228,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 12 '25 |
Sale |
1.75 |
300,000 |
526,230 |
33,628,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 11 '25 |
Sale |
1.83 |
284,805 |
521,421 |
33,928,487 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):